1. Auvert, B., Taljaard, D., Lagarde, E., Sobngwi-Tambekou, J., Sitta, R., et al. (2005). Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: The ANRS 1265 Trial. PLoS Medicone, 2, e298. doi: 10.1371/journal.pmed.0020298 .
2. Bailey, R. C., Moses, S., Parker, C., Agot, K., Maclean, I., et al. (2007). Male circumcision for HIV prevention in young men in Kisumu, Kenya: A randomized controlled trial. Lancet, 369, 643–656.
3. Baltimore, D. (2008). Presidential Address to the American Association for the Advancement of Science, Boston. Reported in BBC News. http://newsvote.bbc.uk . Accessed February 19, 2008.
4. Celum, C., Wald, A., Sanchez, J., Reid, S., Delaney-Morelwe, S., Cowan, F., Fuchs, J., Koblin, B., Corey, L., & HPTN-039. (2008). HSV-2 suppressive therapy for prevention of HIV acquisition: Results of HPTN 039. Presented at the 15th Conference on Retroviruses and Opportunistic Infections, Boston.
5. Eaton, L. A., & Kalichman, S. C. (2007). Risk compensation in HIV prevention: Implications for vaccines, microbicides, and other biomedical HIV prevention technologies. Current HIV/AIDS Reports, 4, 165–172.